We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Explore the differences and similarities between Xiidra and Restasis, two prescription eye drops for chronic dry eye. Learn about their mechanisms, side effects, and when to consult your doctor.

Dry eye disease is a common condition that affects millions of people worldwide, including many in India. It occurs when your eyes don't produce enough tears, or when the tears evaporate too quickly, leading to discomfort and potential vision problems. Fortunately, there are effective treatments available, including prescription eye drops like Xiidra and Restasis. This article will delve into the similarities and differences between these two medications, helping you understand which might be the best choice for your specific needs.
Dry eye disease, also known as keratoconjunctivitis sicca, is a chronic condition characterized by insufficient lubrication of the eyes. This lack of lubrication can stem from two primary issues: either the eyes don't produce enough tears, or the tears that are produced are of poor quality and evaporate too quickly. Symptoms can range from mild irritation to severe pain and can significantly impact daily activities like reading, using a computer, or even blinking.
The symptoms of dry eye disease can vary from person to person, but common signs include:
Several factors can contribute to the development of dry eye disease:
Xiidra and Restasis are both prescription eye drops designed to treat chronic dry eye disease. While they share the common goal of alleviating dry eye symptoms, they work through different mechanisms and have distinct characteristics.
Xiidra's active ingredient is lifitegrast. It works by blocking a protein called LFA-1, which is involved in inflammation that can contribute to dry eye disease. By reducing this inflammation, Xiidra helps to improve tear production and reduce the symptoms of dry eye.
Restasis's active ingredient is cyclosporine. It is an immunomodulator that helps to increase tear production by reducing inflammation in the tear glands. Restasis works to combat the underlying inflammation that can impair the eye's ability to produce tears.
As mentioned, Xiidra targets inflammation by blocking LFA-1, while Restasis works by reducing inflammation to boost tear production. This difference in mechanism means they might be more effective for different individuals or can even be used in combination.
Both medications come as liquid eye drops. Xiidra is a liquid solution, while Restasis is an emulsion, which is a mixture of oil and water. This difference in formulation might affect how the drops feel in the eye for some individuals.
A significant difference lies in their availability as generic medications. Restasis has a generic version available, which can be a more cost-effective option for some patients. Xiidra, however, is currently only available as a brand-name medication.
Both Xiidra and Restasis are typically prescribed to be used twice daily. The specific dosage and administration instructions should always be followed as directed by your eye doctor. It's important to apply the drops correctly to ensure maximum effectiveness and minimize potential side effects.
Studies suggest that Xiidra may provide relief from dry eye symptoms more quickly for some individuals compared to Restasis. However, both medications require consistent use to achieve optimal results. The effectiveness can vary greatly depending on the individual's condition and response to treatment.
Both Xiidra and Restasis can cause side effects, though they are generally mild. Common side effects for both include:
Less common but more serious side effects can include allergic reactions. It is crucial to report any persistent or bothersome side effects to your doctor immediately.
Both medications have been approved for use in certain age groups of children. Restasis can be used in children aged 16 years and older, while Xiidra is approved for children aged 17 years and older. Always consult a pediatrician or pediatric ophthalmologist for treatment decisions concerning children.
Diagnosing dry eye disease typically involves a comprehensive eye examination by an ophthalmologist or optometrist. This may include:
The choice between Xiidra and Restasis, or even using them in combination, depends on several factors:
The American Academy of Ophthalmology guidelines recognize both Xiidra and Restasis as valuable treatment options for chronic dry eye. Sometimes, doctors may recommend using both medications together to achieve better symptom control.
While chronic dry eye may require ongoing medical treatment, certain lifestyle adjustments can help prevent or manage symptoms:
It is essential to consult an eye care professional if you experience persistent symptoms of dry eye. Early diagnosis and treatment can prevent potential complications and improve your quality of life. If your symptoms are severe, interfere with daily activities, or if you are considering prescription treatments like Xiidra or Restasis, seeking professional medical advice is crucial.
Yes, in some cases, doctors may prescribe both Xiidra and Restasis to be used together to manage chronic dry eye disease more effectively. This approach is often considered when a single medication does not provide adequate relief.
Some studies suggest that Xiidra may offer faster symptom relief for certain individuals compared to Restasis. However, both medications require consistent use over time to achieve their full therapeutic benefits. The onset of relief can vary significantly from person to person.
Yes, a generic medication contains the same active ingredient and is required to meet the same standards of safety, quality, and effectiveness as its brand-name counterpart. Therefore, generic Restasis should be as effective as the brand-name version.
The most common side effects for both Xiidra and Restasis include eye irritation, stinging, redness, temporary blurred vision, and an unpleasant taste in the mouth. If you experience any severe or persistent side effects, consult your doctor.
It is important to discuss contact lens wear with your eye doctor when using these medications. Generally, it is recommended to remove contact lenses before applying the eye drops and wait for a specified period (usually 15 minutes) before reinserting them.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.
Visit Hospital
Near You

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026
Find immediate medical attention at 24-hour hospitals in Kamarhati. Learn about emergency services, specialist availability, and when to seek help.
May 20, 2026